NCT02240303

Brief Summary

The aim of this project will be to document the central and peripheral mechanisms, which may predict clinical pain characteristics and associated physical performance in older adults. Although chronic pain is common among older adults, there is limited understanding on the processing of pain and the mechanisms by which it affects physical function in these individuals. The first aim of this study will be to examine predictors of clinical pain in older adults. These will include a comprehensive somatosensory assessment battery including mechanical and thermal detection and pain thresholds in older adults with and without chronic pain. The investigators will also assess basal cognitive and physical function to determine their associations with chronic pain. Finally, brain structure and function will be assessed in these older adults with and without pain.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2015

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2014

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 15, 2014

Completed
7 months until next milestone

Study Start

First participant enrolled

April 1, 2015

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

February 18, 2016

Status Verified

February 1, 2016

Enrollment Period

Same day

First QC Date

September 2, 2014

Last Update Submit

February 16, 2016

Conditions

Keywords

painmobilitybraincognition

Outcome Measures

Primary Outcomes (1)

  • Brain magnetic resonance imaging (MRI)

    Differences in the MRI on the brain scans of participants with greater pain severity

    Baseline and 12 months later

Secondary Outcomes (1)

  • Inflammatory markers in blood samples

    Baseline

Other Outcomes (1)

  • Mobility (gait speed)

    Baseline and 12 months

Study Arms (2)

Chronic Pain Group

Participants that experience chronic pain will have the following procedures performed: A sensory assessment called quantitative sensory testing or QST that will assess in detail your ability to feel sensations due to touch, vibration, and changes in temperature on the skin; Pressure sense will be produced by a device that will be pressed against the skin for several seconds; Pinprick pressure will be applied to determine if the pain can be rated; a Physical Performance test will be performed; and an magnetic resonance imaging (MRI) will be done. In addition, blood sample, blood pressure, heart rate, and skin temperature will be taken during the procedures.

Procedure: Quantitative Sensory Testing (QST)Procedure: Physical PerformanceProcedure: Magnetic Resonance Imaging (MRI)Procedure: Blood Sample

No Chronic Pain Group

Participants that do not experience chronic pain will have the following procedures performed: A sensory assessment called quantitative sensory testing or QST that will assess in detail your ability to feel sensations due to touch, vibration, and changes in temperature on the skin; Pressure sense will be produced by a device that will be pressed against the skin for several seconds; Pinprick pressure will be applied to determine if the pain can be rated; a Physical Performance test will be performed; and an magnetic resonance imaging (MRI) will be done. In addition, blood sample, blood pressure, heart rate, and skin temperature will be taken during the procedures.

Procedure: Quantitative Sensory Testing (QST)Procedure: Physical PerformanceProcedure: Magnetic Resonance Imaging (MRI)Procedure: Blood Sample

Interventions

Participants in both groups will have a sensory assessment called quantitative sensory testing or QST that will assess in detail your ability to feel sensations due to touch, vibration, and changes in temperature on the skin.

Chronic Pain GroupNo Chronic Pain Group

Participants in both groups will have a Physical Performance test.

Chronic Pain GroupNo Chronic Pain Group

Participants in both groups will have an magnetic resonance imaging (MRI).

Chronic Pain GroupNo Chronic Pain Group
Blood SamplePROCEDURE

Participants in both groups will have blood samples taken.

Chronic Pain GroupNo Chronic Pain Group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Older adults

You may qualify if:

  • Age 65 years and older
  • Willingness to participate in all study procedures
  • Cognitively intact as defined by 3MS score \> 80

You may not qualify if:

  • Failure to provide informed consent;
  • Contraindications to MRI, such as claustrophobia, heart pacemaker / defibrillator, heart valve prosthesis, aneurysm clip, metallic stent, neurostimulation system, cochlear implants or inner ear prosthesis, insulin pump or other infusion pump, metal slivers in the orbital area/eye socket
  • Active treatment for cancer or history of cancer in the past year
  • Severe cardiac disease, including New York Heart Association (NYHA) Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest or stroke, use of a cardiac defibrillator, or uncontrolled angina;
  • Previous stroke with upper and/or lower extremities involvement within the last 6 months
  • History of life-threatening cardiac arrhythmias, stroke, severe Parkinson's disease or severe neurological disorders likely to interfere with physical function
  • Renal disease requiring dialysis
  • Lung disease requiring steroids
  • Inability to reliably rate pain intensity
  • Current use of tobacco products
  • Uncontrolled hypertension (BP of greater than 150/99 mm Hg)
  • Serious systemic disease that restrict normal daily activities
  • Neurological problems with significant changes in somatosensory and pain perception at the intended stimulation sites,
  • Uncontrolled psychiatric condition (e.g., experiencing symptoms of schizophrenia, bipolar disorder, etc.) or hospitalization within the preceding year for psychiatric illness
  • Daily use of narcotic medication
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Plasma samples will be stored.

MeSH Terms

Conditions

Pain

Interventions

Physical Functional PerformanceMagnetic Resonance SpectroscopyBlood Specimen Collection

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Physical FitnessHealthPopulation CharacteristicsSpectrum AnalysisChemistry Techniques, AnalyticalInvestigative TechniquesSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, Operative

Study Officials

  • Yenisel Cruz-Almeida, MSPH, PhD

    University of Florida

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 2, 2014

First Posted

September 15, 2014

Study Start

April 1, 2015

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

February 18, 2016

Record last verified: 2016-02